Skip to Content

Join the 'Breast Cancer - Palliative' group to help and get support from people like you.

Breast Cancer - Palliative News

Breast Cancer Equally Common Now Among Blacks, Whites

Posted 29 Oct 2015 by

THURSDAY, Oct. 29, 2015 – Breast cancer is now as common among black women as among whites, although black women continue to have a higher death rate from the disease, an American Cancer Society report says. For decades, black women had lower breast cancer rates than whites, but that gap has narrowed in recent years, the cancer society said. From 2008 to 2012, breast cancer rates rose by 0.4 percent a year among black women, while remaining stable among whites and Hispanics. That means that by 2012, overall breast cancer rates among blacks and whites converged. In fact, the researchers said, rates for black women now exceed those of whites in seven states: Alabama, Kentucky, Louisiana, Mississippi, Missouri, Oklahoma and Tennessee. In addition, black women still tend to fare worse than whites after a breast cancer diagnosis, and breast cancer death rates continue to be higher among ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Shorter Radiation Treatment Works for Early Breast Cancers: Study

Posted 20 Oct 2015 by

TUESDAY, Oct. 20, 2015 – High-dose radiation therapy over a short period of time treats early stage breast cancer as well as longer, conventional radiation therapy does, a new study suggests. Researchers from Fox Chase Cancer Center--Temple Health in Philadelphia report that eight years after treatment, there were no significant differences in survival among hundreds of patients who received intense radiation therapy over four weeks or standard radiation therapy over six to seven weeks. "This is good news for cancer patients because a shorter length of treatment is not only more convenient, but it helps to enable a woman to get her life back to normal after breast cancer treatment," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. "At this time, the shorter radiation therapy is offered to a select group of women," Bernik added. "With more ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, History - Radiation Therapy

Not All Large Breast Tumors Warrant Mastectomy, Study Says

Posted 19 Oct 2015 by

MONDAY, Oct. 19, 2015 – A combination of breast conservation surgery and radiation is as effective as breast removal for some women with large, localized invasive breast tumors, a new study contends. Breast-conserving lumpectomy is usually limited to women with small tumors, the researchers said. "For decades, breast cancers have been felt to be amenable to lumpectomy with radiation only if the tumors were 5 centimeters [nearly 2 inches], or smaller. This is because the prospective trials that compared [lumpectomy and mastectomy] didn't enroll patients whose tumors were larger than 5 centimeters," lead investigator Dr. Richard Bleicher, of the department of surgical oncology at Fox Chase Cancer Center in Philadelphia, explained in a Fox Chase news release. "Since there are no clinical trials evaluating breast conservation therapy versus mastectomy for tumors over 5 centimeters," breast ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, History - Radiation Therapy

Minority Women Get Worse Breast Cancer Care, Regardless of Tumor Type: Study

Posted 13 Oct 2015 by

TUESDAY, Oct. 13, 2015 – No matter the type or stage of breast cancer, minority women are more likely to be diagnosed later in the disease than white women, and they are also less likely to receive recommended treatments, a new study shows. While prior studies have found such disparities before, the new research finds that it exists "across all breast cancer subtypes," study lead author Lu Chen, a researcher in the public health sciences division at Fred Hutchinson Cancer Research Center in Seattle, said in a news release from the American Association for Cancer Research (AACR). The study received funding from the U.S. National Cancer Institute and was published Oct. 13 in the journal Cancer Epidemiology, Biomarkers & Prevention. Chen's team looked at data from 18 U.S. population-based cancer registries. Specifically, the researchers analyzed the demographics, stage of disease, tumor ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

For Early Breast Cancer, More U.S. Women Choose Less Invasive Treatment

Posted 9 Oct 2015 by

FRIDAY, Oct. 9, 2015 – American women with an early, noninvasive stage of breast cancer are increasingly opting for less extensive surgery, a new study says. But there was one exception to the trend: The number of patients who decide to have both breasts removed is growing, even though this method doesn't improve survival, according to the researchers. The study focused on what's known as ductal carcinoma in situ – a very early stage of breast cancer that indicates the presence of noninvasive, yet potentially early cancer cells. "With this analysis, we sought to determine what treatment women selected when diagnosed with [ductal carcinoma in situ], and whether there was any impact in mortality with the different treatments," said study senior author Dr. Shelley Hwang, chief of breast surgery at Duke Cancer Institute in Durham, N.C. The researchers analyzed data from more than 121,000 ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, History - Radiation Therapy

Early Detection Still Key to Breast Cancer Survival: Study

Posted 6 Oct 2015 by

TUESDAY, Oct. 6, 2015 – Even with recent strides in breast cancer treatment, a woman's chances of surviving the disease still partly depend on early detection, a new study says. The study of nearly 174,000 Dutch breast cancer patients found that survival rates improved between 1999 and 2012 – and that included women with more advanced cancer. Still, women's survival odds were best when their tumors were caught early, the researchers reported in the Oct. 6 issue of the medical journal BMJ. "The general prospects for a woman diagnosed with breast cancer in the Western world are very good," said lead researcher Dr. Madeleine Tilanus-Linthorst, of Erasmus University Medical Center in the Netherlands. Her team found that among women diagnosed with breast cancer between 2006 and 2012, the five-year survival rate was 88 percent. That compared with 83 percent among women diagnosed with the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative

News Coverage of Angelina Jolie's Breast Surgery Boosted Awareness of Options

Posted 28 Sep 2015 by

MONDAY, Sept. 28, 2015 – Media coverage of actress Angelina Jolie's breast removal and reconstruction improved awareness about breast reconstruction, a new study suggests. Jolie had both of her breasts removed in 2013 because she has a gene mutation that increased her risk for breast cancer, and then she underwent breast reconstruction surgery. Researchers conducted online surveys with 1,000 women before and after Jolie went public about her surgeries. After her announcement, 4 percent more women were aware that reconstructive breast surgery is possible after one or both breasts are removed. In addition, 11 percent more women were aware that breast reconstruction can be done using a woman's own tissue, and 19 percent more were aware that reconstruction can be done during the breast-removal operation. In the second survey, one-fifth of participants said media coverage about Jolie's ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

New Genetic Clues to Which Breast Cancers Might Return

Posted 24 Sep 2015 by

THURSDAY, Sept. 24, 2015 – Researchers who pinpointed genetic factors associated with the return of breast cancer say their findings might lead to improved treatments. Most breast cancer patients are cured after treatment, but the disease returns in about one in five patients, either in the same location as the original tumor or in other parts of the body, the British researchers said. The researchers analyzed the genes in the tumors of 1,000 breast cancer patients, including 161 whose breast cancer came back. It turned out that there were genetic differences between primary and recurring tumors, according to the study to be presented Sept. 26 at the European Cancer Congress in Vienna. Research presented at meetings should be considered preliminary until published in a peer-reviewed journal. "We have found that some of the genetic mutations that drive breast cancers that relapse are ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative

Travel Time Can Hamper Follow-Up Chemo, Study Says

Posted 24 Aug 2015 by

MONDAY, Aug. 24, 2015 – The farther they have to travel, the less likely cancer patients are to receive follow-up chemotherapy after surgery, a new study finds. This type of treatment, called adjuvant chemotherapy, is recommended for many patients after surgery to reduce the chance of cancer returning. This study looked at nearly 34,700 patients across the United States who had surgery for colon cancer, and found that nearly 76 percent received adjuvant chemotherapy within 90 days of surgery. Compared to patients who had to travel less than 12.5 miles to appointments, those who had to travel 50 to 249 miles were 13 percent less likely to receive chemotherapy. And those who had to travel 250 miles or more were nearly two-thirds less likely to receive chemotherapy. The findings applied to patients with and without insurance, according to the study published online Aug. 24 in the Journal ... Read more

Related support groups: Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative

Higher-Dose, Short-Duration Radiation Better for Early Breast Cancer: Study

Posted 6 Aug 2015 by

THURSDAY, Aug. 6, 2015 – A shorter course of radiation therapy is better for women with early stage breast cancer, according to a new study. Specifically, it found that those who received higher doses of whole breast radiation over a shorter period of time had fewer side effects and a better quality of life than those who received smaller doses of radiation over a longer period of time. "Patients who received the shorter course reported less difficulty in caring for their families' needs. This is a major priority for women undergoing breast cancer radiation," study first author Dr. Simona Shaitelman, from the University of Texas MD Anderson Cancer Center, said in a center news release. "Most are busy working mothers, working inside or outside the home, and are juggling a number of priorities. It's paramount that we address this need," explained Shaitelman, who is an assistant professor ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, History - Radiation Therapy, Osteolytic Bone Metastases of Breast Cancer

After Breast Cancer, Many in Appalachia Say No to Lifesaving Drugs

Posted 27 Jul 2015 by

MONDAY, July 27, 2015 – About one-third of breast cancer survivors in the Appalachian region of the United States do not take potentially lifesaving drugs, even though their drugs are covered by insurance, a new study finds. The study included 428 breast cancer survivors in the Appalachian counties of Kentucky, Ohio, North Carolina and Pennsylvania. All of the women had Medicare Part D insurance that covers prescription medications. About 30 percent of the women did not follow through with their prescribed adjuvant hormone therapy, which reduces the risk of cancer recurrence, the University of Virginia researchers discovered. "Almost a third of the prescriptions for adjuvant hormone therapy were not filled, which is much, much higher compared to what we usually see in commercially insured populations," Rajesh Balkrishnan, of the department of public health sciences, said in a ... Read more

Related support groups: Breast Cancer, Tamoxifen, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Breast Cancer - Adjuvant, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Genox, Teslac, Nolvadex D, Tamofen, Tamosin, Testolactone, Nolvadex

Chemo May Worsen Quality of Life for End-Stage Cancer Patients

Posted 23 Jul 2015 by

THURSDAY, July 23, 2015 – Chemotherapy may worsen quality of life for some cancer patients who are nearing death, a new study finds. "Oncologists may presume there to be no harm in giving dying patients chemotherapy, but these data point to more harm than benefit," study author Dr. Holly Prigerson, from Weill Cornell Medical College in New York City, said in a college news release. The research included more than 300 patients with advanced cancer who had about four months to live. Their average age was about 59. About half of the patients were receiving what's known as palliative chemotherapy when the study began. Palliative chemotherapy is generally given to people who have fewer than six months to live, according to the researchers. The hope is that palliative chemotherapy will ease symptoms and extend survival. But that wasn't the case for those patients who started the study with ... Read more

Related support groups: Cancer, Breast Cancer, Metastatic, Nausea/Vomiting - Chemotherapy Induced, Breast Cancer - Palliative, Neutropenia Associated with Chemotherapy, Hyperuricemia Secondary to Chemotherapy, Anemia - Chemotherapy Induced

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Tretinoin, Lupron Depot, Gleevec, Lung Cancer, Fluorouracil, Colorectal Cancer, Rituxan, Renal Cell Carcinoma

Breast Cancer Survivors Tend to Gain Weight: Study

Posted 15 Jul 2015 by

WEDNESDAY, July 15, 2015 – Among women with a family history of breast cancer, breast cancer survivors tend to gain more weight than women who are free of the disease, new research suggests. And that added weight might increase the risk of heart disease and diabetes, as well as recurrence of the cancer, the researchers said. The researchers compared 303 breast cancer survivors with 307 women who were cancer-free. All were participants in a study of women with a familial risk of breast and ovarian cancer. They included women with BRCA1 and BRCA2 gene mutations that can raise breast cancer risk. "We found that breast cancer survivors, especially those with chemotherapy [treatment], gained more weight compared to cancer-free women," said lead researcher Amy Gross, a doctoral candidate at Johns Hopkins Bloomberg School of Public Health in Baltimore. The study was published July 15 in the ... Read more

Related support groups: Diabetes, Type 2, Obesity, Breast Cancer, Heart Attack, Weight Loss, Insulin Resistance, Pre-Diabetes, Myocardial Infarction, Diabetes Mellitus, Breast Cancer, Prevention, Breast Cancer - Palliative, Abnormal Glucose Tolerance, Myocardial Infarction - Prophylaxis

More Breast Cancer Patients Opting for Lumpectomy: Study

Posted 17 Jun 2015 by

WEDNESDAY, June 17, 2015 – The percentage of women with early stage breast cancer who choose to have the breast-conserving surgery known as lumpectomy has risen slowly in recent years, new research shows. In 1998, slightly more than 54 percent of eligible women chose the surgery. But, the number had passed the 60 percent mark by 2011, according to study author Dr. Isabelle Bedrosian, an associate professor of surgical oncology at the University of Texas M.D. Anderson Cancer Center in Houston. "The big picture shows most women with early stage breast cancer are opting for breast-conserving surgery," she said. Previous research has found that mastectomy, where the entire breast is removed, was chosen as often as lumpectomy among women with early stage breast cancer who were candidates for lumpectomy and the radiation that typically follows it. Bedrosian views the new findings as good ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

estradiol, testosterone, Premarin, tamoxifen, Estrace, ethinyl estradiol, fluorouracil, Zoladex, Megace, view more... megestrol, Estradiol Patch, Cenestin, Enjuvia, Depo-Testosterone, Testopel, Android, Menest, Testopel Pellets, methyltestosterone, goserelin, esterified estrogens, Progynova, conjugated estrogens, Megace ES, Delatestryl, Testred, Methitest, Adrucil, Tamoxifen Hexal, Thais, Virilon IM, Estratab, Everone, Delatest, Testamone-100, Testro AQ, Testoderm, Testolin, Thaissept, Depotest, Histerone, Testro-LA, Testro, FIRST-Testosterone MC, Halotestin, Premarin Intravenous, Meditest, Durathate 200, Andro-Cyp 100, Andro-Cyp 200, Depandro 100, Duratest, Andro LA 200, Genox, Virilon, Estinyl, Android-10, Android-25, Oreton Methyl, Soltamox, Teslac, fluoxymesterone, testolactone, Androxy, Nolvadex, Tamone, Emblon, Zumenon, Sandrena, Primogyn Depot, Oromone, Provames, Progynova TS, Valergen, Tamofen, Nolvadex D, Tamoxen, Tamosin, Systen